Reply to Letter by Tellier et al., 'Scientific refutation of ESHG statement on embryo selection'
- PMID: 36450798
- PMCID: PMC9995443
- DOI: 10.1038/s41431-022-01241-4
Reply to Letter by Tellier et al., 'Scientific refutation of ESHG statement on embryo selection'
Erratum in
-
Correction to: Reply to Letter by Tellier et al., 'Scientific refutation of ESHG statement on embryo selection'.Eur J Hum Genet. 2023 Mar;31(3):368. doi: 10.1038/s41431-022-01263-y. Eur J Hum Genet. 2023. PMID: 36536147 Free PMC article. No abstract available.
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
Scientific refutation of ESHG statement on embryo selection.Eur J Hum Genet. 2023 Mar;31(3):278. doi: 10.1038/s41431-022-01237-0. Epub 2022 Dec 12. Eur J Hum Genet. 2023. PMID: 36503927 Free PMC article. No abstract available.
References
-
- ACMG Board of Directors Direct-to-consumer prenatal testing for multigenic or polygenic disorders: a position statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:2027–8. - PubMed
-
- ESHRE. ESHRE supports the position of ESHG on embryo selection based on polygenic risk scores. 2022. https://www.eshre.eu/Europe/Position-statements/PRS.
-
- ISPG Board Advisory on the use of Polygenic Risk Scores to screen embryos for adult mental health conditions. 2021. https://ispg.net/ethics-statement/.
Publication types
LinkOut - more resources
Full Text Sources
